Virginia / 2026 Regular Session

2026 Regular Session · Imported snapshot

SB669: Pharmacy benefits managers; requirements, application of law, report, delayed effective date.

signed by governor

<b>Pharmacy benefits managers; requirements; scope; report.</b> Requires all health insurance carriers to use the pass-through pricing model and may limit a pharmacy benefits manager from deriving income from pharmacy benefits management services provided to a carrier except for income derived from a pharmacy benefits management fee. The bill prohibits a pharmacy benefits manager from (i) reversing and or resubmitting the claim of a pharmacist or pharmacy without meeting certain requirements, (ii) reducing any payment to a pharmacist or pharmacy to an effective rate of reimbursement, or (iii) retroactively denying or reducing a claim or aggregate of claims except under certain circumstances. The bill requires the State Corporation Commission (the Commission) to examine the practice of carriers or pharmacy benefits managers requiring or inducing covered individuals to utilize pharmacy services at an affiliated pharmacy. The Commission is required to report its findings and recommendations to the General Assembly by December 1, 2027. Certain provisions of the bill have a delayed effective date of July 1, 2027. This bill incorporates SB 410 and SB 413 and is identical to HB 830.

Official bill page · Source: Richmond Sunlight

Ask about SB669

Full bill text

Version CHAP0036 · 2026-03-31 · Official source text

Full text

Changes in this version: added text deleted text

An Act to amend and reenact §§ 38.2-3467 and 38.2-3470 of the Code of Virginia, relating to pharmacy benefits managers; requirements; application of law; report.

Be it enacted by the General Assembly of Virginia:

1. That §§ 38.2-3467 and 38.2-3470 of the Code of Virginia are amended and reenacted as follows:

§ 38.2-3467. Prohibited conduct by carriers and pharmacy benefits managers.

A. No carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager shall:

1. Cause or knowingly permit the use of any advertisement, promotion, solicitation, representation, proposal, or offer that is untrue;

2. Charge a pharmacist or pharmacy a fee (i) related to the adjudication of a claim other than a reasonable fee for an initial claim submission or (ii) to process a claim electronically;

3. Reimburse a pharmacy or pharmacist an amount less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services, calculated on a per-unit basis using the same generic product identifier or generic code number and reflecting all drug manufacturer's rebates, direct and indirect administrative fees, and costs and any remuneration;

4. Penalize or retaliate against a pharmacist or pharmacy for exercising rights provided pursuant to the provisions of this article, including penalizing or retaliating by (i) terminating or refusing to renew a contract with the pharmacist or pharmacy, (ii) subjecting the pharmacist or pharmacy to increased audits without cause, or (iii) failing to promptly pay the pharmacist or pharmacy money owed to such pharmacist or pharmacy;

5. Impose requirements, exclusions, reimbursement terms, or other conditions on a covered entity or contract pharmacy that differ from those applied to entities or pharmacies that are not covered entities or contract pharmacies on the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or pharmacy dispenses 340B-covered drugs. Nothing in this subdivision shall (i) apply to drugs with an annual estimated per-patient cost exceeding $250,000 or (ii) prohibit the identification of a 340B reimbursement request; or

6. Reverse and resubmit the claim of a pharmacist or pharmacy (i) without prior written notification to the pharmacist or pharmacy, (ii) without just cause or attempt to first reconcile the claim with the pharmacist or pharmacy, or (iii) more than one year after the claim was first affirmatively adjudicated;

7. Reduce any payment, directly or indirectly through a reconciliation process, to a pharmacist or pharmacy for pharmacist services to an effective rate of reimbursement, including generic effective rates, brand effective rates, direct and indirect remuneration fees, or any other reduction or aggregate reduction of payment, unless agreed to by the pharmacist or pharmacy in the provider agreement;

8. Retroactively deny or reduce a claim or aggregate of claims unless (i) the original claim was submitted fraudulently, (ii) the pharmacist or pharmacy has already been paid for the pharmacist services, or (iii) the pharmacist services were not properly rendered by the pharmacist or pharmacy; or

9. Interfere with a covered individual's right to choose a pharmacy or provider, based on the pharmacy or provider's status as a covered entity or contract pharmacy.

B. No carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager, shall restrict participation of a pharmacy in a pharmacy network for provider accreditation standards or certification requirements if a pharmacist meets such accreditation standards or certification standards.

C. No carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager, shall include any mail order pharmacy or pharmacy benefits manager affiliate in calculating or determining network adequacy under any law or contract in the Commonwealth.

D. 1. No carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager, shall conduct spread pricing in the Commonwealth.

2. Each carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager shall (i) use the pass-through pricing model and (ii) if requested by a plan sponsor, offer at least one contractual arrangement that limits income from pharmacy benefits management services to income derived from pharmacy benefits management fees for services provided. The amount of any pharmacy benefits management fees under such a contractual arrangement shall be set forth in the agreement between the pharmacy benefits manager and the carrier or health benefit plan.

3. Each carrier, on its own or through its contracted pharmacy benefits manager or a representative of a pharmacy benefits manager, if the contractual arrangement between the pharmacy benefits manager and carrier or health benefit plan delegates the negotiation of rebates to the pharmacy benefits manager or an affiliated entity, the pharmacy benefits manager shall direct 100 percent of all prescription drug manufacturer rebates received to (i) the carrier or health benefit plan for offsetting defined cost sharing, deductibles, and coinsurance contributions and reducing premiums of covered individuals or (ii) the covered individual at the point of sale to reduce such individual's applicable deductible, copayment, coinsurance, or other cost-sharing amount.

4. Compensation arrangements governed by this subsection shall be open for inspection by the Commission. Such arrangements are subject to the confidentiality protections described in § 38.2-3468.

E. The termination of a provider contract with a pharmacy that is not a pharmacy benefits manager affiliate shall not release a carrier or pharmacy benefits manager from the obligation to make any payment due to the pharmacy for an affirmatively adjudicated claim unless any such payment is withheld in relation to an investigation related to insurance fraud.

F. Each carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager shall comply with the provisions of this section in addition to complying with the provisions of § 38.2-3407.15:1.

§ 38.2-3470. Scope of article.

This article shall not apply with respect to claims under (i) an employee welfare benefit plan as defined in section 3 (1) of the Employee Retirement Income Security Act of 1974, 29 U.S.C. § 1002(1), that is self-insured or self-funded; (ii) coverages issued pursuant to Title XIX of the Social Security Act, 42 U.S.C. § 1396 et seq. (Medicaid); or (iii) prescription drug coverages issued pursuant to Part D of Title XVIII of the Social Security Act, 42 U.S.C. § 1395 et seq. (Medicare Part D); or (iv) coverages issued pursuant to Title XXI of the Social Security Act, 42 U.S.C. § 1397 et seq. (CHIP). This article shall apply with respect to claims under the state employee health plan established pursuant to § 2.2-2818.

2. That the State Corporation Commission (the Commission) shall examine the practice of carriers or pharmacy benefits managers, as those terms are defined in § 38.2-3465 of the Code of Virginia, requiring or inducing covered individuals to utilize pharmacy services at a pharmacy benefits manager affiliate, as defined in § 38.2-3465 of the Code of Virginia. The Commission shall report its findings and recommendations to the General Assembly by December 1, 2027.

3. That the provisions of the first enactment of this act shall become effective on July 1, 2027.

Legislative actions

2026-02-25 · history

Delegate Callsen Floor substitute agreed to

2026-02-04 · history

Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)

2026-02-05 · history

Read second time

2026-02-25 · history

Floor substitute printed 26108552D-H2 (Callsen)

2026-02-19 · history

Reported from Labor and Commerce with substitute

2026-02-23 · history

Read second time

2026-02-25 · history

Engrossed by House - floor substitute

2026-02-10 · history

Fiscal Impact Statement from State Corporation Commission (SB669)

2026-02-04 · history

Rules suspended

2026-02-03 · history

Reported from Finance and Appropriations

2026-03-31 · history

Approved by Governor-Chapter 36 (effective 7/1/2026)

2026-03-12 · history

Fiscal Impact Statement from State Corporation Commission (SB669)

2026-01-26 · history

Senate committee offered

2026-01-27 · history

Committee substitute printed 26106220D-S1

2026-02-03 · history

Reported from Finance and Appropriations (15-Y 0-N)

2026-03-31 · history

Approved by Governor-Chapter 36 (Effective 7/1/2027)

2026-02-25 · history

committee substitute rejected

2026-02-25 · history

Read third time

2026-02-04 · history

Passed by for the day Block Vote (Voice Vote)

2026-02-05 · history

Committee substitute agreed to (Voice Vote)

2026-02-04 · history

Passed by for the day

2026-01-14 · history

Prefiled and ordered printed; Offered 01-14-2026 26105407D

2026-01-26 · history

Incorporates SB413 (Peake)

2026-02-25 · history

Floor Offered

2026-02-19 · history

Reported from Labor and Commerce with substitute (20-Y 0-N)

2026-02-27 · history

House substitute agreed to by Senate (38-Y 0-N 0-A)

2026-03-04 · history

Enrolled

2026-01-26 · history

Incorporates SB410 (Peake)

2026-03-31 · history

Acts of Assembly Chapter text (CHAP0036)

2026-03-10 · history

Governor's Action Deadline 11:59 p.m., April 13, 2026

2026-03-04 · history

Signed by Speaker

2026-03-10 · history

Enrolled Bill communicated to Governor on March 10, 2026

2026-02-24 · history

Passed by for the day

2026-01-26 · history

Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (15-Y 0-N)

2026-01-26 · history

Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations

2026-02-12 · history

Referred to Committee on Labor and Commerce

2026-02-12 · history

Placed on Calendar

2026-02-12 · history

Read first time

2026-03-04 · history

Signed by President

2026-02-25 · history

Passed House with substitute (98-Y 0-N 0-A)

2026-02-06 · history

Read third time and passed Senate Block Vote (40-Y 0-N 0-A)

2026-02-05 · history

Commerce and Labor Substitute agreed to

2026-02-24 · history

Moved from Uncontested Calendar to Regular Calendar

2026-01-26 · history

Reported from Commerce and Labor with substitute

2026-02-19 · history

Committee substitute printed 26108250D-H1

2026-02-05 · history

Engrossed by Senate Block Vote (Voice Vote)

2026-02-05 · history

Engrossed by Senate - committee substitute Block Vote (Voice Vote)

2026-03-04 · history

Bill text as passed Senate and House (SB669ER)

2026-01-14 · history

Referred to Committee on Commerce and Labor

Raw source record
{
    "id": 85718,
    "url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/sb669\/",
    "tags": {
        "144674": "health",
        "144675": "insurance",
        "144676": "pharmacy",
        "144677": "regulation"
    },
    "text": [
        {
            "date": "2026-01-20",
            "number": "sb669",
            "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/sb669.pdf"
        },
        {
            "date": "2026-01-27",
            "number": "SB669S1"
        },
        {
            "date": "2026-02-19",
            "number": "SB669H1"
        },
        {
            "date": "2026-02-25",
            "number": "SB669H2"
        },
        {
            "date": "2026-03-04",
            "number": "SB669ER"
        },
        {
            "date": "2026-03-31",
            "number": "CHAP0036"
        }
    ],
    "type": "bill",
    "year": 2026,
    "video": null,
    "number": "sb669",
    "patron": "Rouse, Aaron",
    "status": "signed by governor",
    "chamber": "senate",
    "changes": null,
    "outcome": "passed",
    "related": [
        {
            "id": 84668,
            "name": "Appropriations",
            "year": 2026,
            "count": 4,
            "number": "hb830",
            "status": "signed by governor",
            "catch_line": "Pharmacy benefits managers; requirements, application of law, report, delayed effective date.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 84537,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "hb701",
            "status": "signed by governor",
            "catch_line": "Health and insurance; notice of adverse determination.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 83943,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "hb216",
            "status": "failed committee",
            "catch_line": "Health insurance; coverage for prosthetic and custom orthotic devices and components, reports.",
            "date_introduced": "January 07, 2026"
        },
        {
            "id": 84651,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "hb813",
            "status": "signed by governor",
            "catch_line": "Health insurance; application of cost-sharing prohibitions.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 85388,
            "name": "Education and Health",
            "year": 2026,
            "count": 3,
            "number": "sb410",
            "status": "incorporated",
            "catch_line": "Pharmacy benefits managers; various requirements; report.",
            "date_introduced": "January 13, 2026"
        }
    ],
    "summary": "<b>Pharmacy benefits managers; requirements; scope; report.<\/b> Requires all health insurance carriers to use the pass-through pricing model and may limit a pharmacy benefits manager from deriving income from pharmacy benefits management services provided to a carrier except for income derived from a pharmacy benefits management fee. The bill prohibits a pharmacy benefits manager from (i) reversing and or resubmitting the claim of a pharmacist or pharmacy without meeting certain requirements, (ii) reducing any payment to a pharmacist or pharmacy to an effective rate of reimbursement, or (iii) retroactively denying or reducing a claim or aggregate of claims except under certain circumstances. The bill requires the State Corporation Commission (the Commission) to examine the practice of carriers or pharmacy benefits managers requiring or inducing covered individuals to utilize pharmacy services at an affiliated pharmacy. The Commission is required to report its findings and recommendations to the General Assembly by December 1, 2027. Certain provisions of the bill have a delayed effective date of July 1, 2027. This bill incorporates SB 410 and SB 413 and is identical to HB 830.",
    "version": "CHAP0036",
    "copatron": [
        {
            "shortname": "kcallsen",
            "partisanship": 13,
            "name_formatted": "Del. Katrina Callsen (D-Charlottesville)"
        },
        {
            "shortname": "mjpeake",
            "partisanship": 65,
            "name_formatted": "Sen. Mark Peake (R-Lynchburg)"
        }
    ],
    "committee": "Finance",
    "full_text": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7\u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3467\/'>38.2-3467<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3470\/'>38.2-3470<\/a> of the Code of Virginia, relating to pharmacy benefits managers; requirements; application of law; report.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3467\/'>38.2-3467<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3470\/'>38.2-3470<\/a> of the Code of Virginia are amended and reenacted as follows:<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3467\/'>38.2-3467<\/a>. Prohibited conduct by carriers and pharmacy benefits managers.<\/p><p class=\"section\">A. No carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager shall:<\/p><p class=\"section\">1. Cause or knowingly permit the use of any advertisement, promotion, solicitation, representation, proposal, or offer that is untrue;<\/p><p class=\"section\">2. Charge a pharmacist or pharmacy a fee<em class=\"new\"> (i)<\/ins> related to the adjudication of a claim other than a reasonable fee for an initial claim submission<em class=\"new\"> or (ii) to process a claim electronically<\/ins>;<\/p><p class=\"section\">3. Reimburse a pharmacy or pharmacist an amount less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services, calculated on a per-unit basis using the same generic product identifier or generic code number and reflecting all drug manufacturer's rebates, direct and indirect administrative fees, and costs and any remuneration;<\/p><p class=\"section\">4. Penalize or retaliate against a pharmacist or pharmacy for exercising rights provided pursuant to the provisions of this article<em class=\"new\">, including penalizing or retaliating by (i) terminating or refusing to renew a contract with the pharmacist or pharmacy, (ii) subjecting the pharmacist or pharmacy to increased audits without cause, or (iii) failing to promptly pay the pharmacist or pharmacy money owed to such pharmacist or pharmacy<\/ins>;<\/p><p class=\"section\">5. Impose requirements, exclusions, reimbursement terms, or other conditions on a covered entity or contract pharmacy that differ from those applied to entities or pharmacies that are not covered entities or contract pharmacies on the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or pharmacy dispenses 340B-covered drugs. Nothing in this subdivision shall (i) apply to drugs with an annual estimated per-patient cost exceeding $250,000 or (ii) prohibit the identification of a 340B reimbursement request;<s> or<\/s><\/p><p class=\"section\">6.<em class=\"new\"> Reverse and resubmit the claim of a pharmacist or pharmacy (i) without prior written notification to the pharmacist or pharmacy, (ii) without just cause or attempt to first reconcile the claim with the pharmacist or pharmacy, or (iii) more than one year after the claim was first affirmatively adjudicated;<\/ins><\/p><p class=\"section\"><em class=\"new\">7. Reduce any payment, directly or indirectly through a reconciliation process, to a pharmacist or pharmacy for pharmacist services to an effective rate of reimbursement, including generic effective rates, brand effective rates, direct and indirect remuneration fees, or any other reduction or aggregate reduction of payment, unless agreed to by the pharmacist or pharmacy in the provider agreement;<\/ins><\/p><p class=\"section\"><em class=\"new\">8. Retroactively deny or reduce a claim or aggregate of claims unless (i) the original claim was submitted fraudulently, (ii) the pharmacist or pharmacy has already been paid for the pharmacist services, or (iii) the pharmacist services were not properly rendered by the pharmacist or pharmacy; or<\/ins><\/p><p class=\"section\"><em class=\"new\">9.<\/ins> Interfere with a covered individual's right to choose a pharmacy or provider, based on the pharmacy or provider's status as a covered entity or contract pharmacy.<\/p><p class=\"section\">B. No carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager, shall restrict participation of a pharmacy in a pharmacy network for provider accreditation standards or certification requirements if a pharmacist meets such accreditation standards or certification standards.<\/p><p class=\"section\">C. No carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager, shall include any mail order pharmacy or pharmacy benefits manager affiliate in calculating or determining network adequacy under any law or contract in the Commonwealth.<\/p><p class=\"section\">D. <em class=\"new\">1. <\/ins>No carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager, shall conduct spread pricing in the Commonwealth.<\/p><p class=\"section\"><em class=\"new\">2. Each carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager shall (i) use the pass-through pricing model and (ii) if requested by a plan sponsor, offer at least one contractual arrangement that limits income from pharmacy benefits management services to income derived from pharmacy benefits management fees for services provided. The amount of any pharmacy benefits management fees under such a contractual arrangement shall be set forth in the agreement between the pharmacy benefits manager and the carrier or health benefit plan.<\/ins><\/p><p class=\"section\"><em class=\"new\">3. Each carrier, on its own or through its contracted pharmacy benefits manager or a representative of a pharmacy benefits manager, if the contractual arrangement between the pharmacy benefits manager and carrier or health benefit plan delegates the negotiation of rebates to the pharmacy benefits manager or an affiliated entity, the pharmacy benefits manager shall direct 100 percent of all prescription drug manufacturer rebates received to (i) the carrier or health benefit plan for offsetting defined cost sharing, deductibles, and coinsurance contributions and reducing premiums of covered individuals or (ii) the covered individual at the point of sale to reduce such individual's applicable deductible, copayment, coinsurance, or other cost-sharing amount.<\/ins><\/p><p class=\"section\"><em class=\"new\">4. Compensation arrangements governed by this subsection shall be open for inspection by the Commission. Such arrangements are subject to the confidentiality protections described in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3468\/'>38.2-3468<\/a>.<\/ins><\/p><p class=\"section\">E.<em class=\"new\"> The termination of a provider contract with a pharmacy that is not a pharmacy benefits manager affiliate shall not release a carrier or pharmacy benefits manager from the obligation to make any payment due to the pharmacy for an affirmatively adjudicated claim unless any such payment is withheld in relation to an investigation related to insurance fraud.<\/ins><\/p><p class=\"section\"><em class=\"new\">F.<\/ins> Each carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager shall comply with the provisions of this section in addition to complying with the provisions of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:1\/'>38.2-3407.15:1<\/a>.<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3470\/'>38.2-3470<\/a>. Scope of article.<\/p><p class=\"section\">This article shall not apply with respect to claims under (i) an employee welfare benefit plan as defined in section 3 (1) of the Employee Retirement Income Security Act of 1974, 29 U.S.C. \u00a7 1002(1), that is self-insured or self-funded; (ii) coverages issued pursuant to Title XIX of the Social Security Act, 42 U.S.C. \u00a7 1396 et seq. (Medicaid);<s> or<\/s> (iii) prescription drug coverages issued pursuant to Part D of Title XVIII of the Social Security Act, 42 U.S.C. \u00a7 1395 et seq. (Medicare Part D)<em class=\"new\">; or (iv) coverages issued pursuant to Title XXI of the Social Security Act, 42 U.S.C. \u00a7 1397 et seq. (CHIP)<\/ins>.<em class=\"new\"> This article shall apply with respect to claims under the state employee health plan established pursuant to \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/2.2-2818\/'>2.2-2818<\/a>.<\/ins><\/p><p class=\"enactcls\">2. That the State Corporation Commission (the Commission) shall examine the practice of carriers or pharmacy benefits managers, as those terms are defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3465\/'>38.2-3465<\/a> of the Code of Virginia, requiring or inducing covered individuals to utilize pharmacy services at a pharmacy benefits manager affiliate, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3465\/'>38.2-3465<\/a> of the Code of Virginia. The Commission shall report its findings and recommendations to the General Assembly by December 1, 2027.<\/p><p class=\"enactcls\">3. That the provisions of the first enactment of this act shall become effective on July 1, 2027.<\/p>",
    "catch_line": "Pharmacy benefits managers; requirements, application of law, report, delayed effective date.",
    "duplicates": null,
    "session_id": 32,
    "word_count": 1444,
    "patron_party": "D",
    "patron_place": "Virginia Beach",
    "summary_hash": "d5950668c05fed5391110dd3d63fbb20",
    "patron_prefix": "Sen.",
    "patron_suffix": "(D-Virginia Beach)",
    "status_detail": "signed by governor",
    "_rsun_versions": [
        {
            "id": "9a4bb3fd6cba72b1fa63dc2b09916b2e0938468c1fd0d48d3b5016ccc0e4316a",
            "code": "CHAP0036",
            "bill_id": 85718,
            "source_url": null,
            "source_date": "2026-03-31",
            "source_hash": "e5ffd56ca0722b1e4ef100e526d3f4b42743c5f6629ec2fc94c54ebf380c748d",
            "source_html": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7\u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3467\/'>38.2-3467<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3470\/'>38.2-3470<\/a> of the Code of Virginia, relating to pharmacy benefits managers; requirements; application of law; report.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3467\/'>38.2-3467<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3470\/'>38.2-3470<\/a> of the Code of Virginia are amended and reenacted as follows:<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3467\/'>38.2-3467<\/a>. Prohibited conduct by carriers and pharmacy benefits managers.<\/p><p class=\"section\">A. No carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager shall:<\/p><p class=\"section\">1. Cause or knowingly permit the use of any advertisement, promotion, solicitation, representation, proposal, or offer that is untrue;<\/p><p class=\"section\">2. Charge a pharmacist or pharmacy a fee<em class=\"new\"> (i)<\/ins> related to the adjudication of a claim other than a reasonable fee for an initial claim submission<em class=\"new\"> or (ii) to process a claim electronically<\/ins>;<\/p><p class=\"section\">3. Reimburse a pharmacy or pharmacist an amount less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services, calculated on a per-unit basis using the same generic product identifier or generic code number and reflecting all drug manufacturer's rebates, direct and indirect administrative fees, and costs and any remuneration;<\/p><p class=\"section\">4. Penalize or retaliate against a pharmacist or pharmacy for exercising rights provided pursuant to the provisions of this article<em class=\"new\">, including penalizing or retaliating by (i) terminating or refusing to renew a contract with the pharmacist or pharmacy, (ii) subjecting the pharmacist or pharmacy to increased audits without cause, or (iii) failing to promptly pay the pharmacist or pharmacy money owed to such pharmacist or pharmacy<\/ins>;<\/p><p class=\"section\">5. Impose requirements, exclusions, reimbursement terms, or other conditions on a covered entity or contract pharmacy that differ from those applied to entities or pharmacies that are not covered entities or contract pharmacies on the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or pharmacy dispenses 340B-covered drugs. Nothing in this subdivision shall (i) apply to drugs with an annual estimated per-patient cost exceeding $250,000 or (ii) prohibit the identification of a 340B reimbursement request;<s> or<\/s><\/p><p class=\"section\">6.<em class=\"new\"> Reverse and resubmit the claim of a pharmacist or pharmacy (i) without prior written notification to the pharmacist or pharmacy, (ii) without just cause or attempt to first reconcile the claim with the pharmacist or pharmacy, or (iii) more than one year after the claim was first affirmatively adjudicated;<\/ins><\/p><p class=\"section\"><em class=\"new\">7. Reduce any payment, directly or indirectly through a reconciliation process, to a pharmacist or pharmacy for pharmacist services to an effective rate of reimbursement, including generic effective rates, brand effective rates, direct and indirect remuneration fees, or any other reduction or aggregate reduction of payment, unless agreed to by the pharmacist or pharmacy in the provider agreement;<\/ins><\/p><p class=\"section\"><em class=\"new\">8. Retroactively deny or reduce a claim or aggregate of claims unless (i) the original claim was submitted fraudulently, (ii) the pharmacist or pharmacy has already been paid for the pharmacist services, or (iii) the pharmacist services were not properly rendered by the pharmacist or pharmacy; or<\/ins><\/p><p class=\"section\"><em class=\"new\">9.<\/ins> Interfere with a covered individual's right to choose a pharmacy or provider, based on the pharmacy or provider's status as a covered entity or contract pharmacy.<\/p><p class=\"section\">B. No carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager, shall restrict participation of a pharmacy in a pharmacy network for provider accreditation standards or certification requirements if a pharmacist meets such accreditation standards or certification standards.<\/p><p class=\"section\">C. No carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager, shall include any mail order pharmacy or pharmacy benefits manager affiliate in calculating or determining network adequacy under any law or contract in the Commonwealth.<\/p><p class=\"section\">D. <em class=\"new\">1. <\/ins>No carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager, shall conduct spread pricing in the Commonwealth.<\/p><p class=\"section\"><em class=\"new\">2. Each carrier, on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager shall (i) use the pass-through pricing model and (ii) if requested by a plan sponsor, offer at least one contractual arrangement that limits income from pharmacy benefits management services to income derived from pharmacy benefits management fees for services provided. The amount of any pharmacy benefits management fees under such a contractual arrangement shall be set forth in the agreement between the pharmacy benefits manager and the carrier or health benefit plan.<\/ins><\/p><p class=\"section\"><em class=\"new\">3. Each carrier, on its own or through its contracted pharmacy benefits manager or a representative of a pharmacy benefits manager, if the contractual arrangement between the pharmacy benefits manager and carrier or health benefit plan delegates the negotiation of rebates to the pharmacy benefits manager or an affiliated entity, the pharmacy benefits manager shall direct 100 percent of all prescription drug manufacturer rebates received to (i) the carrier or health benefit plan for offsetting defined cost sharing, deductibles, and coinsurance contributions and reducing premiums of covered individuals or (ii) the covered individual at the point of sale to reduce such individual's applicable deductible, copayment, coinsurance, or other cost-sharing amount.<\/ins><\/p><p class=\"section\"><em class=\"new\">4. Compensation arrangements governed by this subsection shall be open for inspection by the Commission. Such arrangements are subject to the confidentiality protections described in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3468\/'>38.2-3468<\/a>.<\/ins><\/p><p class=\"section\">E.<em class=\"new\"> The termination of a provider contract with a pharmacy that is not a pharmacy benefits manager affiliate shall not release a carrier or pharmacy benefits manager from the obligation to make any payment due to the pharmacy for an affirmatively adjudicated claim unless any such payment is withheld in relation to an investigation related to insurance fraud.<\/ins><\/p><p class=\"section\"><em class=\"new\">F.<\/ins> Each carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager shall comply with the provisions of this section in addition to complying with the provisions of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:1\/'>38.2-3407.15:1<\/a>.<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3470\/'>38.2-3470<\/a>. Scope of article.<\/p><p class=\"section\">This article shall not apply with respect to claims under (i) an employee welfare benefit plan as defined in section 3 (1) of the Employee Retirement Income Security Act of 1974, 29 U.S.C. \u00a7 1002(1), that is self-insured or self-funded; (ii) coverages issued pursuant to Title XIX of the Social Security Act, 42 U.S.C. \u00a7 1396 et seq. (Medicaid);<s> or<\/s> (iii) prescription drug coverages issued pursuant to Part D of Title XVIII of the Social Security Act, 42 U.S.C. \u00a7 1395 et seq. (Medicare Part D)<em class=\"new\">; or (iv) coverages issued pursuant to Title XXI of the Social Security Act, 42 U.S.C. \u00a7 1397 et seq. (CHIP)<\/ins>.<em class=\"new\"> This article shall apply with respect to claims under the state employee health plan established pursuant to \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/2.2-2818\/'>2.2-2818<\/a>.<\/ins><\/p><p class=\"enactcls\">2. That the State Corporation Commission (the Commission) shall examine the practice of carriers or pharmacy benefits managers, as those terms are defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3465\/'>38.2-3465<\/a> of the Code of Virginia, requiring or inducing covered individuals to utilize pharmacy services at a pharmacy benefits manager affiliate, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3465\/'>38.2-3465<\/a> of the Code of Virginia. The Commission shall report its findings and recommendations to the General Assembly by December 1, 2027.<\/p><p class=\"enactcls\">3. That the provisions of the first enactment of this act shall become effective on July 1, 2027.<\/p>",
            "source_metadata": {
                "bodyAssociation": "archive-reported-current-version",
                "archiveReference": {
                    "date": "2026-03-31",
                    "number": "CHAP0036"
                }
            }
        }
    ],
    "copatron_count": 2,
    "patron_address": [
        "P.O. Box 2864",
        "Virginia Beach",
        "VA 23450"
    ],
    "patron_chamber": "senate",
    "patron_started": 2023,
    "session_lis_id": 261,
    "status_history": [
        {
            "date": "03\/31\/2026",
            "status": "Approved by Governor-Chapter 36 (Effective 7\/1\/2027)",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "03\/31\/2026",
            "status": "Acts of Assembly Chapter text (CHAP0036)",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/31\/2026",
            "status": "Approved by Governor-Chapter 36 (effective 7\/1\/2026)",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "03\/12\/2026",
            "status": "Fiscal Impact Statement from State Corporation Commission (SB669)",
            "date_raw": "2026-03-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/10\/2026",
            "status": "Governor's Action Deadline 11:59 p.m., April 13, 2026",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/10\/2026",
            "status": "Enrolled Bill communicated to Governor on March 10, 2026",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Signed by President",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed"
        },
        {
            "date": "03\/04\/2026",
            "status": "Signed by Speaker",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Bill text as passed Senate and House (SB669ER)",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Enrolled",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/27\/2026",
            "status": "House substitute agreed to by Senate (38-Y 0-N 0-A)",
            "date_raw": "2026-02-27",
            "vote_count": null,
            "lis_vote_id": "299579",
            "translation": null
        },
        {
            "date": "02\/25\/2026",
            "status": "Passed House with substitute (98-Y 0-N 0-A)",
            "date_raw": "2026-02-25",
            "vote_count": null,
            "lis_vote_id": "298929",
            "translation": "passed house"
        },
        {
            "date": "02\/25\/2026",
            "status": "Engrossed by House - floor substitute",
            "date_raw": "2026-02-25",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/25\/2026",
            "status": "Delegate Callsen Floor substitute agreed to",
            "date_raw": "2026-02-25",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/25\/2026",
            "status": "committee substitute rejected",
            "date_raw": "2026-02-25",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/25\/2026",
            "status": "Read third time",
            "date_raw": "2026-02-25",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/25\/2026",
            "status": "Floor Offered",
            "date_raw": "2026-02-25",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/25\/2026",
            "status": "Floor substitute printed 26108552D-H2 (Callsen)",
            "date_raw": "2026-02-25",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/24\/2026",
            "status": "Passed by for the day",
            "date_raw": "2026-02-24",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/24\/2026",
            "status": "Moved from Uncontested Calendar to Regular Calendar",
            "date_raw": "2026-02-24",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/23\/2026",
            "status": "Read second time",
            "date_raw": "2026-02-23",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/19\/2026",
            "status": "Committee substitute printed 26108250D-H1",
            "date_raw": "2026-02-19",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/19\/2026",
            "status": "Reported from Labor and Commerce with substitute (20-Y 0-N)",
            "date_raw": "2026-02-19",
            "vote_count": null,
            "lis_vote_id": "298241",
            "translation": "passed committee"
        },
        {
            "date": "02\/19\/2026",
            "status": "Reported from Labor and Commerce with substitute",
            "date_raw": "2026-02-19",
            "vote_count": null,
            "lis_vote_id": "298241",
            "translation": "passed committee"
        },
        {
            "date": "02\/12\/2026",
            "status": "Referred to Committee on Labor and Commerce",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "02\/12\/2026",
            "status": "Read first time",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Placed on Calendar",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/10\/2026",
            "status": "Fiscal Impact Statement from State Corporation Commission (SB669)",
            "date_raw": "2026-02-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/06\/2026",
            "status": "Read third time and passed Senate  Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-02-06",
            "vote_count": null,
            "lis_vote_id": "295167",
            "translation": "passed senate"
        },
        {
            "date": "02\/05\/2026",
            "status": "Engrossed by Senate - committee substitute Block Vote (Voice Vote)",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/05\/2026",
            "status": "Commerce and Labor Substitute agreed to",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": "294782",
            "translation": null
        },
        {
            "date": "02\/05\/2026",
            "status": "Engrossed by Senate  Block Vote (Voice Vote)",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": "294783",
            "translation": null
        },
        {
            "date": "02\/05\/2026",
            "status": "Committee substitute agreed to (Voice Vote)",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/05\/2026",
            "status": "Read second time",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/04\/2026",
            "status": "Passed by for the day",
            "date_raw": "2026-02-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/04\/2026",
            "status": "Passed by for the day  Block Vote (Voice Vote)",
            "date_raw": "2026-02-04",
            "vote_count": null,
            "lis_vote_id": "294455",
            "translation": null
        },
        {
            "date": "02\/04\/2026",
            "status": "Constitutional reading dispensed  Block Vote (on 1st reading) (40-Y 0-N 0-A)",
            "date_raw": "2026-02-04",
            "vote_count": null,
            "lis_vote_id": "294454",
            "translation": null
        },
        {
            "date": "02\/04\/2026",
            "status": "Rules suspended",
            "date_raw": "2026-02-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/03\/2026",
            "status": "Reported from Finance and Appropriations (15-Y 0-N)",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": "293970",
            "translation": "passed committee"
        },
        {
            "date": "02\/03\/2026",
            "status": "Reported from Finance and Appropriations",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed committee"
        },
        {
            "date": "01\/27\/2026",
            "status": "Committee substitute printed 26106220D-S1",
            "date_raw": "2026-01-27",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/26\/2026",
            "status": "Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (15-Y 0-N)",
            "date_raw": "2026-01-26",
            "vote_count": null,
            "lis_vote_id": "292289",
            "translation": "passed committee"
        },
        {
            "date": "01\/26\/2026",
            "status": "Incorporates SB413 (Peake)",
            "date_raw": "2026-01-26",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/26\/2026",
            "status": "Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations",
            "date_raw": "2026-01-26",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed committee"
        },
        {
            "date": "01\/26\/2026",
            "status": "Incorporates SB410 (Peake)",
            "date_raw": "2026-01-26",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/26\/2026",
            "status": "Reported from Commerce and Labor with substitute",
            "date_raw": "2026-01-26",
            "vote_count": null,
            "lis_vote_id": "292286",
            "translation": "passed committee"
        },
        {
            "date": "01\/26\/2026",
            "status": "Senate committee offered",
            "date_raw": "2026-01-26",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/14\/2026",
            "status": "Referred to Committee on Commerce and Labor",
            "date_raw": "2026-01-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "01\/14\/2026",
            "status": "Prefiled and ordered printed; Offered 01-14-2026 26105407D",
            "date_raw": "2026-01-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "introduced"
        }
    ],
    "chief_patron_id": 493,
    "date_introduced": "2026-01-14",
    "patron_district": 22,
    "patron_shortname": "arrouse",
    "committee_chamber": "senate",
    "status_detail_date": "03\/31\/2026",
    "committee_shortname": "finance",
    "patron_name_formatted": "Sen. Aaron Rouse (D-Virginia Beach)"
}